Chemotherapy of soft tissue sarcomas.
The medical treatment of advanced soft tissue sarcomas in adults is reviewed. Response rates of 40--50% are obtainable after various polychemotherapies, mainly containing doxorubicin and dacarbazine. Response to secondary treatment is very poor and indicates the need for further clinical research in these infrequent malignant tumors.